Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122617454 | 12261745 | 4 | F | 20160404 | 20160809 | 20160413 | 20160815 | EXP | PHEH2016US008954 | NOVARTIS | 69.82 | YR | F | Y | 0.00000 | 20160815 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122617454 | 12261745 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 1-2: 0.0625 MG (0.25 ML), QOD | Y | 125290 | .062 | MG | SOLUTION FOR INJECTION | ||||||
| 122617454 | 12261745 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEK 3-4, 0.125 MG, (0.5 ML), QOD | Y | 125290 | .125 | MG | SOLUTION FOR INJECTION | ||||||
| 122617454 | 12261745 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEK 5-6, 0.1875 MG, (0.75 ML), QOD | Y | 125290 | .187 | MG | SOLUTION FOR INJECTION | ||||||
| 122617454 | 12261745 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 7+: 0.25 MG, QOD | Y | 125290 | .25 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122617454 | 12261745 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122617454 | 12261745 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122617454 | 12261745 | Asthenia | |
| 122617454 | 12261745 | Cardiomyopathy | |
| 122617454 | 12261745 | Chest discomfort | |
| 122617454 | 12261745 | Coronary artery disease | |
| 122617454 | 12261745 | Diarrhoea | |
| 122617454 | 12261745 | Dizziness | |
| 122617454 | 12261745 | Electrocardiogram abnormal | |
| 122617454 | 12261745 | Gait disturbance | |
| 122617454 | 12261745 | Hypertension | |
| 122617454 | 12261745 | Influenza like illness | |
| 122617454 | 12261745 | Insomnia | |
| 122617454 | 12261745 | Myocardial infarction | |
| 122617454 | 12261745 | Nausea | |
| 122617454 | 12261745 | Pain | |
| 122617454 | 12261745 | Pallor | |
| 122617454 | 12261745 | Palpitations | |
| 122617454 | 12261745 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122617454 | 12261745 | 1 | 20160404 | 0 | ||
| 122617454 | 12261745 | 4 | 20160803 | 0 |